Cardiac transplantation, also known as heart transplantation, is a life-saving medical procedure designed to address end-stage heart failure. This complex surgical intervention involves replacing a failing or damaged heart with a healthy donor heart, enabling patients to regain cardiac function and improve their overall quality of life. Candidates for cardiac transplantation typically suffer from severe heart conditions that are unresponsive to other forms of treatment. The success of a cardiac transplant relies on meticulous donor-recipient matching, advanced surgical techniques, and postoperative care. While cardiac transplantation offers a second chance at life for many patients, challenges such as organ shortages and the risk of rejection remain significant concerns. Advances in immunosuppressive medications have significantly improved outcomes, minimizing the risk of rejection and enhancing long-term survival rates. Despite the complexities associated with cardiac transplantation, it stands as a testament to the remarkable achievements of modern medicine in addressing critical cardiac conditions and extending the lives of those in need.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India